| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.043 | 0.7 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |